PETALING JAYA: Despite the challenging environment, these are opportune times for the pharmaceutical industry.
While the industry like others, bears the brunt of the pandemic, there is also the possibility of a Covid-19 vaccine which is expected to be available in the first or second quarter of next year.
Among the frontrunners for the fill-and-finish work of the vaccine, Pharmaniaga Bhd
and Duopharma Biotech Bhd, are set to compete and deepen their presence in the competitive pharmaceutical space where multinational companies like Pfizer, Merck Sharp & Dohme, Novartis and Sanofi hold the lion share.
...
